【論文・学会活動～英文総説他～】熊本大学病院　乳腺・内分泌外科

016: Suyama K, Iwase H.
Lenvatinib: A Promising Molecular Targeted Agent for Multiple Cancers.
Cancer Control. 25(1):1073274818789361, 2018.
015: Nakao M, Fujiwara S, Iwase H.
Cancer Navigation Strategy for Endocrine Therapy-Resistant Breast Tumors.
Trends Cancer. 4(6):404-407, 2018.
014: Yamamoto Y, Tamura K.
Preface for special issue "Advances in treatment and care in metastatic breast cancer".
Chin Clin Oncol. 7(3):22, 2018.

013: Yamamoto-Ibusuki M, Arnedos M, André F.
Targeted therapies for ER+/HER2- metastatic breast cancer.
BMC Med., 9, 13, 137, 2015
012: Omoto Y, Iwase H.,
Clinical significance of estrogen receptor β in breast and prostate cancer from biological aspects.
Cancer Sci., 106, 4, 337-43, 2015
011: Iwase H, Yamamoto Y.
Clinical benefit of sequential use of endocrine therapies for metastatic breast cancer.
Int J Clin Oncol. 20, 2, 253-61, 2015
010: Iwase H.
Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor.
Int J Clin Oncol. 20, 2, 249-52, 2015.

009: Yamamoto Y, Yamamoto-Ibusuki M, Iwase H.
Menopausal Status Should Be Taken Into Consideration for Patients With Luminal A Breast Cancer in Terms of the Effect of Differential Biology on Prognosis.
J Clin Oncol. 31 19 2516 2013

008: Yamamoto Y, Kawano I, Iwase H.
Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval.
Onco Targets Ther. 4 123-136 2011

007: Yamamoto Y, Iwase H.
Clinicopathological features and treatment strategy for triple-negative breast cancer.
Int J Clin Oncol. 15 4 341-51 2010

006: Iwase H, Yamamoto Y, Kawasoe T, Ibusuki M.
Advantage of sentinel lymph node biopsy before neoadjuvant chemotherapy in breast cancer treatment.
Surg Today. 39 5 374-80 2009
005: Akiyama F, Iwase H.
Triple negative breast cancer: clinicopathological characteristics and treatment strategies.
Breast Cancer. 16 4 252-253 2009

004: Yamamoto Y, Iwase H.
Safety profiles of aromatase inhibitors and selective estrogen-receptor modulators in the treatment for early breast cancer.
Int J Clin Oncol. 13 384-394 2008
003: Iwase H.
Current topics and perspectives in the treatment of endocrine-related cancers.
Int J Clin Oncol. 13 5 384-394 2008
002: Iwase H.
Current topics and perspectives on the use of aromatase inhibitors in the treatment of breast cancer.
Breast Cancer. 15 4 278-290 2008

001: Iwase H, Yamamoto Y, Zhang Z.
Estrogen receptor structure and function in breast cancer pathogenesis.
Reproductive Oncology. 121-134 2007